Concepedia

Francesca Alvarez‐Calderon

FA

Statistics

Publications

11

Citations

614

H-Index

10

Active since

2007

Affiliations

Dana-Farber Cancer Institute(Current)

Boston Children's Hospital

Harvard University

University of Colorado Denver

Massachusetts General Hospital

Francesca Alvarez‐Calderon is an author at Dana-Farber Cancer Institute specializing in life sciences, oncology, and molecular oncology.

ORCID

Publications per year

2007–2024

11

Publications

11

Wnt/Ca2+/NFAT Signaling Maintains Survival of Ph+ Leukemia Cells upon Inhibition of Bcr-Abl

Mark A. Gregory, Tzu Phang, Paolo Neviani et al. · Cancer Cell · 2010 · 186 citations · Full text

, , +14

Macular pigment response to a supplement containing meso-zeaxanthin, lutein and zeaxanthin

Richard A. Bone, John T. Landrum, Yisi Cao et al. · Nutrition & Metabolism · 2007 · 105 citations · Full text

, , +10

ATM/G6PD-driven redox metabolism promotes FLT3 inhibitor resistance in acute myeloid leukemia

Mark A. Gregory, Angelo D’Alessandro, Francesca Alvarez‐Calderon et al. · Proceedings of the National Academy of Sciences · 2016 · 105 citations · Full text

, , +17

Tyrosine Kinase Inhibition in Leukemia Induces an Altered Metabolic State Sensitive to Mitochondrial Perturbations

Francesca Alvarez‐Calderon, Mark A. Gregory, Catherine Pham‐Danis et al. · Clinical Cancer Research · 2014 · 67 citations · Full text

, , +17

Human OX40L–CAR-T <sub>regs</sub> target activated antigen-presenting cells and control T cell alloreactivity

Xianliang Rui, Francesca Alvarez‐Calderon, Holly Wobma et al. · Science Translational Medicine · 2024 · 34 citations · Full text

, , +16

1–5 of 11